Publications: Berry, Cassandra
2013
Le, X., Poinern, G.E.J., Ali, N., Berry, C.M. and Fawcett, D. (2013) Engineering a biocompatible scaffold with either micrometre or nanometre scale surface topography for promoting protein adsorption and cellular response. International Journal of Biomaterials, 2013 . pp. 1-16.
2012
Berry, C.M., Hertzog, P.J. and Mangan, N.E. (2012) Interferons as biomarkers and effectors: lessons learned from animal models. Biomarkers in Medicine, 6 (2). pp. 159-176.
2011
Bayer, W., Lietz, R., Ontikatze, T., Johrden, L., Tenbusch, M., Nabi, G., Schimmer, S., Groitl, P., Wolf, H., Berry, C.M., Überla, K., Dittmer, U. and Wildner, O. (2011) Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes. Retrovirology, 8 (1). p. 75.
2010
Chua, T-H, Leung, C.Y.H., Fang, H. E., Chow, Ch-K, Ma, S-K, Sia, S-F, Ng, I.H.Y., Fenwick, S.G., James, C.M., Chua, S.B., Chew, S.T., Kwang, J., Peiris, J.S.M. and Ellis, T.M. (2010) Evaluation of a subunit H5 vaccine and an inactivated H5N2 avian influenza marker vaccine in ducks challenged with Vietnamese H5N1 highly pathogenic avian influenza virus. Influenza Research and Treatment, 2010 . pp. 1-10.
James-Berry, C.M., Middleton, D., Mansfield, J.P., Fenwick, S.G. and Ellis, T.M. (2010) Use of a tetanus toxoid marker to allow differentiation of infected from vaccinated poultry without affecting the efficacy of a H5N1 avian influenza virus vaccine. Veterinary Record, 167 (18). pp. 695-699.
2009
Gerlach, N., Gibbert, K., Alter, C., Nair, S., Zelinskyy, G., James, C.M. and Dittmer, U. (2009) Anti-retroviral effects of type I IFN subtypes in vivo. European Journal of Immunology, 39 (1). pp. 136-146.
Eade, J.A., Robertson, I.D. and James-Berry, C.M. (2009) Contraceptive potential of porcine and feline zona pellucida A, B and C subunits in domestic cats. Reproduction, 137 (6). pp. 913-922.
2008
James-Berry, C.M., Foong, Y.Y., Mansfield, J.P., Vind, A.R., Fenwick, S.G. and Ellis, T.M. (2008) Evaluation of a positive marker of avian influenza vaccination in ducks for use in H5N1 surveillance. Vaccine, 26 (42). pp. 5345-5351.
James, C.M., Duffy, S., Pemberton, D., Armson, A. and Stumbles, P. (2008) Interferon subtype stimulation of dendritic cells: Key activators of anti-viral immunity. Cytokine, 43 (3). p. 309.
2007
James-Berry, C.M., Abdad, M.Y., Mansfield, J.P., Jacobsen, H.K., Vind, A.R., Stumbles, P.A. and Bartlett, E.J. (2007) Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein. Vaccine, 25 (10). pp. 1856-1867.
James, C.M., Lisciandro, J., Gerlach, N., Dittmer, U. and Stumbles, P.A. (2007) Interferon-alpha subtypes differentially enhance dendritic cell biology. In: International Society for Interferon and Cytokine Research, Interferon Anniversary Meeting, 16 - 19 September, Oxford, England.
James-Berry, C.M., Foong, Y.Y., Mansfield, J.P., Fenwick, S.G. and Ellis, T.M. (2007) Use of tetanus toxoid as a differentiating infected from vaccinated animals (DIVA) strategy for sero-surveillance of avian influenza virus vaccination in poultry. Vaccine, 25 (31). pp. 5892-5901.
2006
Austin, B.A., James-Berry, C.M., Härle, P. and Carr, D.J.J. (2006) Direct application of plasmid DNA containing type I interferon transgenes to vaginal mucosa inhibits HSV-2 mediated mortality. Biological Procedures Online, 8 (1). pp. 55-62.
2005
James, C.M., Bartlett, E.J., Mansfield, J.P. and Cull, V.S. (2005) Interferon subtype gene therapy for regulating cytomegalovirus disease. Methods in molecular medicine, 116 . pp. 207-219.
